Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Prepaid Assets (2016 - 2025)

Cytosorbents (CTSO) has disclosed Prepaid Assets for 14 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 127.59% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2025, up 127.59%, and an annual FY2024 reading of $3.3 million, up 78.31% over the prior year.
  • Prepaid Assets was $2.3 million for Q3 2025 at Cytosorbents, up from $1.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.3 million in Q4 2024 and bottomed at $880363.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $2.0 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Prepaid Assets tumbled 52.75% in 2024, then skyrocketed 256.3% in 2025.
  • Year by year, Prepaid Assets stood at $2.9 million in 2021, then decreased by 13.34% to $2.5 million in 2022, then fell by 26.28% to $1.8 million in 2023, then soared by 78.31% to $3.3 million in 2024, then fell by 28.22% to $2.3 million in 2025.
  • Business Quant data shows Prepaid Assets for CTSO at $2.3 million in Q3 2025, $1.3 million in Q2 2025, and $3.1 million in Q1 2025.